Physician profile
Danny J Garcia
NPI 1598148595
$1,112.67
in general payments reported to CMS, 2019-2025
16 companies · $800 in 2025
The $800 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $38.02 · 2024: $275 · 2025: $800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $191.54 | 2024-2025 | Mounjaro, Zepbound |
| Viiv Healthcare Company | $158.78 | 2025 | Apretude |
| Exact Sciences Corporation | $94.32 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Novo Nordisk INC | $94.31 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Shield Therapeutics INC | $77.32 | 2023-2024 | Accrufer |
| Merck Sharp & Dohme LLC | $72.74 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
| Gilead Sciences, INC. | $68.34 | 2025 | |
| Amgen INC. | $65.15 | 2025 | Repatha, Otezla |
| Boston Scientific Corporation | $62.05 | 2025 | Avvigo Guidance System, Synergy |
| Hologic Sales and Service, LLC | $59.93 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Astellas Pharma US INC | $57.66 | 2025 | Veozah |
| Dexcom, INC. | $34.54 | 2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $21.94 | 2025 | |
| Sanofi Pasteur INC. | $20.19 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.50 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $16.36 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.